Sort
64,565 grants matching “drug discovery”
Mycobacterium tuberculosis environmental signal integration: single cell in vivo understanding of its influence on infection heterogeneity and treatment efficacy
$620,485Shumin Tan · Tufts University Boston · R01 · FY2019 · AI
Advancing Knowledge Discovery for Postoperative Pain Management
$620,483Tina Hernandez-Boussard · Stanford University · R01 · FY2023 · LM
NIDA Epidemiology Training Program
$620,403C Debra Furr-Holden · Johns Hopkins University · T32 · FY2013 · DA
Rational generation of high-performance recombinant antibodies to post-translational modifications
$620,370Takamitsu Hattori · New York University School Of Medicine · R21 · FY2020 · CA
Preclinical optimization of a parasiticidal drug for cryptosporidiosis
$620,271Christopher D Huston · University Of Vermont & St Agric College · R01 · FY2021 · AI
Preclinical optimization of a parasiticidal drug for cryptosporidiosis
$620,271Christopher D Huston · University Of Vermont & St Agric College · R01 · FY2020 · AI
Discovery of New Anti-Inflammatory Agents to Treat COPD
$620,269Mikell Paige · George Mason University · R01 · FY2016 · HL
Modeling Cardiovascular Risks of Air Pollutants with Human Induced Pluripotent Stem Cell-Derived Cardiovascular-Associated Cells (Project 3) for the Air pollution disrupts Inflammasome Regulation in
$620,255Joseph C Wu · Stanford University · P01 · FY2021 · HL
Characterization of novel insulin resistance genes by gene editing, high-throughput phenotyping and in vivo studies
$620,254Joshua Wiley Knowles · Stanford University · R01 · FY2023 · DK
Therapeutic approaches for LKB1-deficient non-small cell lung cancer
$620,252John V. Heymach · University Of Tx Md Anderson Can Ctr · R01 · FY2016 · CA
Modeling Cardiovascular Risks of Air Pollutants with Human Induced Pluripotent Stem Cell-Derived Cardiovascular-Associated Cells (Project 3) for the Air pollution disrupts Inflammasome Regulation in
$620,156Joseph C Wu · Stanford University · P01 · FY2022 · HL
Small-molecule STAT3 degraders
$620,148Shaomeng Wang · University Of Michigan At Ann Arbor · R01 · FY2021 · CA
The hippocampal dentate gyrus in aging and Alzheimer's disease: boosting transcription of retinoic acid-sensitive genes through vitamin A supplementation and HDAC inhibition
$620,095John Joshua Lawrence · Texas Tech University Health Scis Center · R01 · FY2025 · AG
Decoding Methylation Mediated Epigenomic Contributions to Male Osteoporosis
$620,035Hong-Wen Deng · Tulane University Of Louisiana · R01 · FY2020 · AR
CETP and HDL Function in Cardiovascular Diseases
$620,011Yuqing E Chen · University Of Michigan At Ann Arbor · R01 · FY2016 · HL
Genetics and Molecular Biology Parkinsonism
$620,000Dennis William Dickson · Mayo Clinic Jacksonville · P50 · FY2011 · NS
A Structural Systems Biology Approach to Drug Discovery
$620,000Rommie E Amaro · University Of California, San Diego · DP2 · FY2015 · OD
Structural Basis of Signal Instigation Through Family C GPCRs
$619,967Georgios Skiniotis · Stanford University · R01 · FY2022 · NS
SBIR Phase II: Development of Novel Dendrimer-based Technologies for Phosphorylation Analyses
$619,948Anton Iliuk · Tymora Analytical Operations, Llc · · FY2013 · TIP
Using patient-derived models to understand drug responses in SCLC
$619,923Nicholas J Dyson · Massachusetts General Hospital · U01 · FY2020 · CA
Using patient-derived models to understand drug responses in SCLC
$619,923Nicholas J Dyson · Massachusetts General Hospital · U01 · FY2018 · CA
Targeting RAGE/DIAPH1: Novel Therapeutic Strategy for Diabetic Complications
$619,879Ann Marie Schmidt · New York University School Of Medicine · R01 · FY2022 · DK
SPORE IN PROSTATE CANCER
$619,876Johns Hopkins University · P50 · FY2003 · CA
Frataxin deficiency as a cause of endothelial senescence in multiple subtypes of pulmonary hypertension
$619,875Stephen Y Chan · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · HL
A CETR-based partnership accelerator for rapid drug development targeting SARS-CoV-2 and pan-CoVs
$619,850David S Perlin · Hackensack University Medical Center · U19 · FY2020 · AI